LGND
Ligand Pharmaceuticals Inc.
$234.68
-2.86%
-6.92
Notify me if price changes either direction
Buy LGND stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
4.8B
Enterprise value
4.5B
Trailing PE
39.37948
Forward PE
22.229189
PEG Ratio
-0.16517224347826
Enterprise to EBITDA
56.062
Enterprise to revenue
16.933
Price to book MRQ
4.700245
Price to sales TTM
10.939615
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
268.1M
EBITDA
94.5M
Diluted EPS TTM
6.14
Total Cash (MRQ)
733.5M
Current ratio (MRQ)
22.225
Operating Cash Flow (TTM)
49.4M
LGND trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
April 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
